Total assets increased 51.2%
Total assets changed +51.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +51.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +36.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +43.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +37.7% from the comparable as-filed period.
Inventory changed +48.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +1012 basis points from the comparable as-filed period.
Research & development changed +55.8% from the comparable as-filed period.
Operating income changed +31.3% from the comparable as-filed period.
Operating cash flow changed +45.8% from the comparable as-filed period.
Capex / revenue changed +369 basis points from the comparable as-filed period.
Current assets changed +15.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +33.7% from the comparable as-filed period.
SBC / revenue changed -338 basis points from the comparable as-filed period.
Capital expenditure changed +144.9% from the comparable as-filed period.
Free-cash-flow margin changed -328 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -19.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Short-term borrowings changed -0.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -1797 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed +351 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -174.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Shares outstanding changed +5.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Stock-based compensation changed +10.4% from the comparable as-filed period.
Working capital changed +5.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory / revenue changed +74 basis points from the comparable as-filed period.
Selling, general & administrative changed +5.4% from the comparable as-filed period.
Receivables / revenue changed -52 basis points from the comparable as-filed period.
Operating cash-flow margin changed +40 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.